-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
-
Summary
-
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly/annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest history and growth rate from 2020 to 2023.
- NEUROONE MEDICAL TECHNOLOGIES Corp Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending June 30, 2024 was -$2.77M, a 20.2% increase year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending June 30, 2024 was -$12.1M, a 19.8% decline year-over-year.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was -$11.9M, a 18.6% decline from 2022.
- NEUROONE MEDICAL TECHNOLOGIES Corp annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was -$10M.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Growth (%)